Akm E. Ullah

Array ( [id] => 7359480 [patent_doc_number] => 20040014218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same' [patent_app_type] => new [patent_app_number] => 10/380809 [patent_app_country] => US [patent_app_date] => 2003-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5726 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014218.pdf [firstpage_image] =>[orig_patent_app_number] => 10380809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362348 [patent_doc_number] => 20040014772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Compositions and methods for treating glomerular disorders' [patent_app_type] => new [patent_app_number] => 10/385416 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 11119 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014772.pdf [firstpage_image] =>[orig_patent_app_number] => 10385416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821634 [patent_doc_number] => 20030219795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'SCDs as modifiers of the p53 pathway and methods of use' [patent_app_type] => new [patent_app_number] => 10/377133 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16743 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219795.pdf [firstpage_image] =>[orig_patent_app_number] => 10377133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821632 [patent_doc_number] => 20030219793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'High bone mass gene of 11q13.3' [patent_app_type] => new [patent_app_number] => 10/374979 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 40851 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219793.pdf [firstpage_image] =>[orig_patent_app_number] => 10374979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7462088 [patent_doc_number] => 20040166091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Materials and methods for treating disorders of the ear' [patent_app_type] => new [patent_app_number] => 10/373249 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14730 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20040166091.pdf [firstpage_image] =>[orig_patent_app_number] => 10373249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580853 [patent_doc_number] => 07449308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Combinatorial DNA library for producing modified N-glycans in lower eukaryotes' [patent_app_type] => utility [patent_app_number] => 10/371877 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 44 [patent_no_of_words] => 45857 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449308.pdf [firstpage_image] =>[orig_patent_app_number] => 10371877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005038 [patent_doc_number] => 20050170351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Materials and methods relating to cancer diagnosis' [patent_app_type] => utility [patent_app_number] => 10/505626 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27413 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170351.pdf [firstpage_image] =>[orig_patent_app_number] => 10505626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710408 [patent_doc_number] => 20060051753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Methods for determining the response of cells to vegf and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/504077 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20378 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051753.pdf [firstpage_image] =>[orig_patent_app_number] => 10504077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931128 [patent_doc_number] => 20050282163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Polymorphisms in elastin, fibrillin and related genes as predisposing to restenosis and to a therosclerosis' [patent_app_type] => utility [patent_app_number] => 10/502984 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6362 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282163.pdf [firstpage_image] =>[orig_patent_app_number] => 10502984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829196 [patent_doc_number] => 20030180254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Immunologic enhancement with intermittent interleukin-2 therapy' [patent_app_type] => new [patent_app_number] => 10/351274 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15571 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180254.pdf [firstpage_image] =>[orig_patent_app_number] => 10351274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 716584 [patent_doc_number] => 07053262 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Mammary gland tissue-specific expression system using β-casein promoter site of Korean native goat' [patent_app_type] => utility [patent_app_number] => 10/347718 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9237 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053262.pdf [firstpage_image] =>[orig_patent_app_number] => 10347718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856221 [patent_doc_number] => 20030129722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids' [patent_app_type] => new [patent_app_number] => 10/341845 [patent_app_country] => US [patent_app_date] => 2003-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18220 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129722.pdf [firstpage_image] =>[orig_patent_app_number] => 10341845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851010 [patent_doc_number] => 20030143213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Methods for increasing a cytotoxic T lymphocyte response in vivo' [patent_app_type] => new [patent_app_number] => 10/340275 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 23504 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143213.pdf [firstpage_image] =>[orig_patent_app_number] => 10340275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 963559 [patent_doc_number] => 06949371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-27 [patent_title] => 'Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/338691 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 28 [patent_no_of_words] => 21921 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/949/06949371.pdf [firstpage_image] =>[orig_patent_app_number] => 10338691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7447730 [patent_doc_number] => 20040003422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Upstream control elements of the proopiomelanocortin gene and their use' [patent_app_type] => new [patent_app_number] => 10/336091 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28204 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20040003422.pdf [firstpage_image] =>[orig_patent_app_number] => 10336091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6656029 [patent_doc_number] => 20030106079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Adult T cell leukemia model animal' [patent_app_type] => new [patent_app_number] => 10/319564 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3602 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20030106079.pdf [firstpage_image] =>[orig_patent_app_number] => 10319564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7119148 [patent_doc_number] => 20050071895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Generation of transgenic mice by transgene-mediated rescue of spermatogenesis' [patent_app_type] => utility [patent_app_number] => 10/498113 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6328 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20050071895.pdf [firstpage_image] =>[orig_patent_app_number] => 10498113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6793539 [patent_doc_number] => 20030088883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Transgenic constructs for studying fibrotic diseases and uses thereof' [patent_app_type] => new [patent_app_number] => 10/306171 [patent_app_country] => US [patent_app_date] => 2002-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6787 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20030088883.pdf [firstpage_image] =>[orig_patent_app_number] => 10306171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952221 [patent_doc_number] => 20050227315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Exogenous protein expression system in an avian system' [patent_app_type] => utility [patent_app_number] => 10/496397 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19140 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227315.pdf [firstpage_image] =>[orig_patent_app_number] => 10496397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797096 [patent_doc_number] => 20030175970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Recombinational cloning using nucleic acids having recombination sites' [patent_app_type] => new [patent_app_number] => 10/300892 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 29573 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175970.pdf [firstpage_image] =>[orig_patent_app_number] => 10300892 [rel_patent_id] =>[rel_patent_doc_number] =>)